MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, IART made $1,635,245K in revenue. -$516,474K in net income. Net profit margin of -31.58%.

Income Overview

Revenue
$1,635,245K
Net Income
-$516,474K
Net Profit Margin
-31.58%
EPS
-$6.74
Unit: Thousand (K) dollars
Revenue Breakdown
    • Neurosurgery
    • Regenerative Skin And Wound
    • Instruments
    • Others
Revenue Breakdown
    • Codman Specialty Surgical
    • Tissue Technologies
Revenue Breakdown
    • US
    • Asia Pacific
    • Europe
    • Rest Of The World

Income Statement
2025-12-31
2024-12-31
Total revenue, net
1,635,245 1,610,527
Cost of goods sold
803,625 728,466
Research and development
98,971 115,377
Selling, general and administrative
699,700 716,983
Intangible asset amortization
14,954 21,290
Goodwill impairment charge
511,365 -
Total costs and expenses
2,128,615 1,582,116
Operating (loss) income
-493,370 28,411
Interest income
18,474 20,040
Interest expense
86,255 70,632
Other (expense) income, net
-2,351 3,944
(loss) income before income taxes
-563,502 -18,237
(benefit) provision for income taxes
-47,028 -11,293
Net (loss) income
-516,474 -6,944
Basic EPS
-6.74 -0.09
Diluted EPS
-6.74 -0.09
Basic Average Shares
76,672,000 77,010,000
Diluted Average Shares
76,672,000 77,010,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) income-$516,474K (-7337.70%↓ Y/Y)(benefit) provision forincome taxes-$47,028K (-316.43%↓ Y/Y)Neurosurgery$827,667K (2.97%↑ Y/Y)Instruments$206,472K (1.12%↑ Y/Y)ENT$166,372K (22.65%↑ Y/Y)Regenerative Skin And Wound$323,488K (-7.72%↓ Y/Y)Private Label$111,246K (-4.37%↓ Y/Y)(loss) income beforeincome taxes-$563,502K (-2989.88%↓ Y/Y)Interest income$18,474K (-7.81%↓ Y/Y)Codman SpecialtySurgical$1,200,511K (4.97%↑ Y/Y)Tissue Technologies$434,734K (-6.89%↓ Y/Y)Operating (loss) income-$493,370K (-1836.55%↓ Y/Y)Interest expense$86,255K (22.12%↑ Y/Y)Total revenue, net$1,635,245K (1.53%↑ Y/Y)Other (expense)income, net-$2,351K (-159.61%↓ Y/Y)Total costs andexpenses$2,128,615K (34.54%↑ Y/Y)Cost of goods sold$803,625K (10.32%↑ Y/Y)Selling, general andadministrative$699,700K (-2.41%↓ Y/Y)Goodwill impairmentcharge$511,365K Research and development$98,971K (-14.22%↓ Y/Y)Intangible assetamortization$14,954K (-29.76%↓ Y/Y)

INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

INTEGRA LIFESCIENCES HOLDINGS CORP (IART)